T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
1826
Xenia Hotels & Resorts
XHR
$1.73B
| $921K | ﹤0.01% |
78,147
-6,430
| -8% | -$77.5K |
|
|
AMWD
1827
DELISTED
American Woodmark
AMWD
| $917K | ﹤0.01% |
12,125
-1,793
| -13% | -$135K |
|
1828
WaFd
WAFD
$2.79B
| $914K | ﹤0.01% |
35,669
+3,327
| +10% | +$93K |
|
1829
Stepan Co
SCL
$1.48B
| $913K | ﹤0.01% |
12,166
+526
| +5% | +$46K |
|
1830
Sonos
SONO
$1.86B
| $912K | ﹤0.01% |
70,616
+5,057
| +8% | +$75K |
|
1831
Xerox
XRX
$412M
| $912K | ﹤0.01% |
58,068
+3,225
| +6% | +$50.9K |
|
1832
AAR Corp
AIR
$5.96B
| $910K | ﹤0.01% |
15,270
+2,359
| +18% | +$140K |
|
|
JWN
1833
DELISTED
Nordstrom
JWN
| $910K | ﹤0.01% |
60,902
+8,408
| +16% | +$154K |
|
1834
Ennis
EBF
$556M
| $907K | ﹤0.01% |
42,741
+7,139
| +20% | +$152K |
|
1835
Asana
ASAN
$2.28B
| $906K | ﹤0.01% |
49,434
+3,199
| +7% | +$66.9K |
|
1836
CarGurus
CARG
$3.29B
| $906K | ﹤0.01% |
51,704
-1,103
| -2% | -$21.8K |
|
1837
Vicor
VICR
$10.4B
| $904K | ﹤0.01% |
15,350
+4,207
| +38% | +$279K |
|
1838
Allegro MicroSystems
ALGM
$7.92B
| $899K | ﹤0.01% |
28,140
+1,990
| +8% | +$80.8K |
|
1839
Koppers
KOP
$857M
| $898K | ﹤0.01% |
22,689
-554
| -2% | -$21K |
|
1840
Construction Partners
ROAD
$6.9B
| $898K | ﹤0.01% |
24,560
-23
| -0.1% | -$759 |
|
1841
JetBlue
JBLU
$2.18B
| $895K | ﹤0.01% |
194,460
-1,861,937
| -91% | -$12.2M |
|
1842
Phreesia
PHR
$780M
| $893K | ﹤0.01% |
47,727
-16,194
| -25% | -$436K |
|
1843
Aclaris Therapeutics
ACRS
$860M
| $890K | ﹤0.01% |
129,887
+80,907
| +165% | +$691K |
|
|
VRE
1844
DELISTED
Veris Residential
VRE
| $889K | ﹤0.01% |
53,855
+3,729
| +7% | +$65.6K |
|
1845
RadNet
RDNT
$6.06B
| $886K | ﹤0.01% |
31,429
+4,769
| +18% | +$148K |
|
1846
Astrana Health
ASTH
$1.78B
| $886K | ﹤0.01% |
28,697
+1,720
| +6% | +$59.4K |
|
1847
Pediatrix Medical
MD
$2.15B
| $885K | ﹤0.01% |
69,615
+13,909
| +25% | +$191K |
|
1848
IHS Holding
IHS
$2.82B
| $884K | ﹤0.01% |
159,105
-12,825
| -7% | -$95K |
|
1849
Kennametal
KMT
$2.35B
| $879K | ﹤0.01% |
35,301
+1,815
| +5% | +$49.1K |
|
1850
Beam Therapeutics
BEAM
$2.74B
| $874K | ﹤0.01% |
36,325
+2,100
| +6% | +$56.3K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.